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Background: Kaempferol has been reported as beneficial for both acute and chronic inflammatory diseases. This
study aims to investigate whether kaempferol affects systemic inflammation and oxidative stress in the heart, lung,
and liver after hemorrhagic shock in mice.
Methods: Male C57/BL6 mice underwent hemorrhagic shock (mean arterial pressure of 35 mmHg for 90 min) and
were arbitrarily divided into Sham, hemorrhagic shock (HS), and Kae groups (n = 10 in each group). Mice in the Kae
groups received a kaempferol (10-mg/kg body weight) injection 12 h prior to (Group Kae PT) or 90 min after (Group
Kae T) the initiation of hemorrhagic shock. Plasma proinflammatory cytokines (TNF-α and IL-6), organ myeloperoxidase
(MPO) and superoxide dismutase (SOD) activities, and organ malondialdehyde (MDA) concentrations and heme
oxygenase-1 (HO-1) expression levels were assessed by enzyme-linked immunosorbent assay (ELISA) or western
blot assay.
Results: Compared with the HS group and the Kae T group, pretreatment with kaempferol significantly decreased
proinflammatory cytokines TNF-α (P = 0.012 and 0.015, respectively) and IL-6 (P = 0.023 and 0.014, respectively)
following hemorrhagic shock. Kae pretreatment reverted MPO, SOD, and MDA to basal levels in the heart, lung,
and liver (Ps < 0.05), while the Kae T group showed no significant differences in these biomarkers compared with
the HS group (Ps > 0.05). HO-1 expression was significantly increased in the Kae PT group compared with the other
groups (P = 0.011 vs. HS group and P = 0.02 vs. Kae T group).
Conclusions: Pretreatment of hemorrhagic shock mice with kaempferol significantly decreased plasma levels of
TNF-α and IL-6; reverted MPO, SOD, and MDA in the heart, lung, and liver; and increased expression of HO-1 in the
same organs.
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Hemorrhagic shock (HS) is one of the most common
causes of deaths related to severe trauma [1,2]. HS is
generally characterized by hemodynamic instability with
cellular hypoxia and diminishing organ function [3].
Trauma and HS may stimulate a systemic release of
endogenous molecules and provoke local and systemic
liberation of both pro- and anti-inflammatory cytokines
such as interleukin-1 beta (IL-1β), IL-2, IL-4, and tumor* Correspondence: doctoryanzhao@163.com
1Emergency Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei
430071, China
Full list of author information is available at the end of the article
© 2015 Yang et al.; licensee BioMed Central. T
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.necrosis factor-alpha (TNF-α) [4,5]. Thus, severe and
developing HS ultimately results in systematic inflamma-
tory response syndrome or multiple organ failure and
even death [6]. In addition, oxidative stress is implicated
in the high mortality and morbidity of HS [6], and treat-
ment with antioxidative stress agents could improve the
outcome of HS [7-9].
Kaempferol is believed to have anti-inflammatory
activities. It has been shown to have potential immune-
modulatory effects and to interfere with a number of
inflammation mechanisms in vitro [10,11]. Kowalski et al.
[11] demonstrated that kaempferol blocks expression of
both IL-1β and TNF-α in macrophages. Kaempferolhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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IL-2- and IL-4-mediated inflammatory outcomes [12,13].
Although both antioxidant and pro-oxidant activities of
flavonoids have been previously studied [14,15], the anti-
oxidant or pro-oxidant ability of kaempferol in HS has not
been investigated.
This study aims to investigate whether kaempferol
affects systematic inflammation and oxidative stress in
the heart, lung, and liver after HS in mice.
Methods and materials
Animals
Forty 8–10-week-old specific pathogen-free male C57/
BL6 mice weighing 20–25 g were purchased from the
Center for Animal Experiment of Wuhan University
(Wuhan, Hubei, China). The Research Committee of
Wuhan University approved this study (No. 20130037).
All experiments were conducted in accordance with the
guidelines of the Animal Use and Care Committee of
Wuhan University. Mice were housed individually in
cages on a 12-h day/12-h night cycle at 23 − 27°C and
had free access to food and water.
Animal model
An HS model was used as previously described [16].
Briefly, animals were anesthetized with an intraperito-
neal (i.p.) injection of pentobarbital sodium (50-mg/kg
body weight [BW]; Amresco, Cleveland, OH, USA). Can-
nulation was performed using sterile polyethylene tubing
on both right and left femoral arteries. All the catheters
and syringes were pretreated with heparinized normal
saline (25 IU/mL, Shuanghe, Beijing, China). The right
femoral artery cannulation tube was connected with a
pressure transducer to the BL-420 F biological signal ac-
quisition system (Chengdu Taineng Ltd., Chengdu, China).
Mean arterial pressure (MAP) was recorded throughout
this experiment. HS was performed by withdrawing blood
over a 15-min interval via the left femoral artery cannula-
tion tube. MAP was controlled at 30–40 mmHg for
90 min followed by 15-min fluid resuscitation using an
equal volume of normal saline as lost blood. Thereafter,
the catheter was removed, the artery ligated, and the skin
incision closed. After a recovery phase of 4.5 h, the mice
were sacrificed. Blood samples, and heart, lung, and liver
tissue were collected for biochemical analysis.
Group distribution
Mice were arbitrarily divided into four groups: (1) a Sham
group (n = 10): animals received femoral artery catheteri-
zations without drawing blood; (2) a hemorrhagic shock
(HS) group (n = 10): animals underwent HS and received
an i.p. injection of 100-μL phosphate-buffered saline (PBS)
(Boster, Wuhan, China) at the end of the 90-min shock
period; (3) a kaempferol pretreatment (Kae PT) group(n = 10): animals received an injection of kaempferol
(Sigma, St. Louis, MO, USA) (i.p., 10 mg/kg BW, dissolved
in 100 μL of PBS) 12 h prior to the initiation of HS; and
(4) a kaempferol treatment (Kae T) group (n = 10): HS
animals received a kaempferol injection (i.p., 10 mg/kg
BW in 100 μL of PBS) at the end of the shock period
(Figure 1).
Plasma TNF-α and IL-6 measurements
At the end of the study, blood samples were collected by
cardiac puncture. Heparinized blood samples were cen-
trifuged (5415D, Eppendorf, Germany) at 1200 × g for
10 min at 4°C. Thereafter, supernatants were stored at
−80°C until measurements. Plasma cytokines including
TNF-α (Cat no. MTA00B) and IL-6 (Cat no. M6000B)
were measured by commercial enzyme-linked immuno-
sorbent assay (ELISA) kits (R&D Systems Inc., Minneap-
olis, MN, USA) according to the manufacturer’s protocols.
Myeloperoxidase activity
Fresh heart, lung, and liver tissues were frozen at the
end of the study. Tissue was homogenized in a lysis buf-
fer before the determination of myeloperoxidase (MPO)
activity. MPO activity was determined by a commercial
ELISA kit (Cat no. LS-F278-1, Biocompare, CA, USA)
according to the manufacturer’s protocols. Previous
studies [16,17] have reported observations of only minor
histological changes following HS models. Therefore, we
did not perform histological evaluation in this study.
Malondialdehyde levels
Fresh tissue was placed into a 1.5-ml centrifuge tube.
RIPA Buffer 250 μL was added with protease inhibitors.
Homogenate was then centrifuged at 11000 × g for 10 min
at 4°C. The supernatant was used for determining malon-
dialdehyde (MDA) by a commercial kit (Cat no. 10009055,
Cayman, Ann Arbor, MI).
Superoxide dismutase activity
The supernatant of homogenate after centrifuge (12,000 ×
g, 10 min; 5415D, Eppendorf, Germany) was used for
detecting superoxide dismutase (SOD) activity. Tissue
SOD activity was measured with a SOD-525TM reagent
kit (OXIS International, Foster, CA, USA); the final re-
sult was expressed as U/mg protein.
Heme oxygenase-1 expression in organs
Western blot assay was used to detect the expression of
heme oxygenase-1 (HO-1) in the main organs after HS.
Briefly, 40-μg protein extracts were loaded onto a 10%
resolving gel for electrophoresis. Proteins were trans-
blotted onto membranes (Millipore, Temecula, CA,
USA). Then, membranes were blocked for 1 h at room
temperature. The blot was immune-probed overnight
Figure 1 Study protocol. Animals were assigned to Sham (n = 10), HS (n = 10), Kae T (n = 10), and Kae PT (n = 10) groups. The HS group received an
injection of 100-μL PBS (i.p.) at the end of the shock period. Kae T and Kae PT groups received an injection of kaempferol (i.p., 10 mg/kg BW, dissolved
in 100-μL PBS) 90 min following or 12 h prior to the initiation of HS, respectively. Animals were sacrificed 6 h after the initiation of HS for blood and
tissue sample collection.
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Cambridge, MA, USA) and β-actin (1:1000; Santa Cruz
Biotechnology, Dallas, TX, USA). The blots were incu-
bated with a secondary antibody for 1 h at room
temperature. The signals were detected by enhanced
chemiluminescene (ECL) and quantified by Photoshop
CS6 software (Adobe, USA).
Statistical analysis
Data were processed using the statistical analysis soft-
ware SPSS version 18.0 (SPSS Inc., Chicago, IL, USA)
and were expressed as mean ± SD. Comparisons of sev-
eral means were performed using one-way and repeated
measures two-way analysis of variance followed by the
Tukey–Kramer test to identify significant differences
between groups. All statistical significance tests were
two-tailed and P values of less than 0.05 were consid-
ered significant.
Results
General characteristics of mice
The general characteristics of animals were shown in
Table 1. The average BW and age were similar for all
groups. MAP was recorded throughout the experiments.Table 1 General characteristics in all groups (mean ± SD)
Groups (n) Age (d) Body weight (g)
Sham (10) 63 ± 5 23.0 ± 1.5
HS (10) 63 ± 5 22.0 ± 1.2
Kae PT (10) 64 ± 4 23.3 ± 1.5
Kae T (10) 64 ± 5 22.1 ± 2.4
1MAP-in-HS: MAP during a 90-min HS period; 2MAP-post-HS: MAP after normal salin
biological signal acquisition system. No significant differences were found in age an
were significantly higher in the Sham group than in the HS, Kae PT, and Kae T grouMAP during the HS period (MAP-in-HS) and after
fluid resuscitation (MAP-post-HS) was calculated.
MAP dramatically decreased after blood withdrawals,
and MAP in the HS period was well controlled at
30–40 mmHg. There were no significant differences in
MAP-in-HS and MAP-post-HS between the HS, Kae
PT, and Kae T groups (HS vs. Kae PT, P = 0.14; Kae PT
vs. Kae T, P = 0.32; HS vs. Kae T, P = 0.10). However,
both MAP-in-HS and MAP-post-HS were significantly
higher in the Sham group than in the HS, Kae PT, and
Kae T groups (MAP-in-HS: P = 0.001, 0.002, and 0.001,
respectively and MAP-post-HS: P = 0.012, 0.011, and
0.036, respectively).
Measurements of plasma cytokines
Compared with the Sham group, the plasma levels
of TNF-α and IL-6 were significantly increased after
HS in the HS (P = 0.001), Kae PT (P = 0.001), and Kae T
(P = 0.0034) groups (Figure 2). The i.p. injection of
kaempferol 12 h prior to the initiation of HS inhibited
the release of both TNF-α (P = 0.012 vs. HS; P = 0.015
vs. Kae T) and IL-6 (P = 0.023 vs. HS; P = 0.014 vs. Kae T),
while the injection of kaempferol 90 min following HS
affected neither the plasma TNF-α nor the IL-6 levels.MAP-in-HS1 (mmHg) MAP-post-HS2 (mmHg)
85.4 ± 7.5## 82.6 ± 6.4#
36.4 ± 3.0 74.5 ± 5.5
35.0 ± 2.9 78.8 ± 6.0
36.2 ± 3.5 76.5 ± 7.0
e resuscitation; MAP was automatically recorded and calculated via a BL-420 F
d body weight between groups. However, both MAP-in-HS and MAP-post-HS
ps. Compared with the other groups, #P < 0.05, ##P < 0.01.
Figure 2 Changes of plasma TNF-α (A) and IL-6 (B) in all groups. Both TNF-α and IL-6 significantly increased after HS. Pretreatment with
kaempferol reverted these two cytokines to basal levels. Compared with the other groups, #P < 0.05, ##P < 0.01.
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The MPO activities were measured in the heart, lung,
and liver (Figure 3). Elevated cardiac, pulmonary, and
hepatic MPO activities were observed after HS in the
HS, Kae PT, and Kae T groups. There was no significant
difference in MPO activity between the HS and Kae T
groups (P = 0.34, 0.19, and 0.074 in the heart, lung, and
liver, respectively). However, the MPO activity was sig-
nificantly decreased in the Kae PT group compared with
the HS and Kae T groups (heart: P = 0.018 and 0.01;
lung: P = 0.024 and 0.017; liver: P = 0.011 and 0.031,
respectively).
Organ oxidative response
We evaluated the MDA levels and SOD activities in the
heart, lung, and liver to investigate the effects of kaemp-
ferol on oxidative response following HS. As seen in
Figure 4, MDA levels were significantly higher in the HS
groups than in the Sham group (P = 0.001, 0.016, and
0.011 in the heart, lung, and liver, respectively), while
SOD activities were decreased in the HS groups com-
pared with the Sham group (P = 0.001, 0.023, and 0.010
in the heart, lung, and liver, respectively). The injection
of kaempferol following HS (Kae T) showed no effectsFigure 3 MPO activities in heart (A), lung (B), and liver (C). Elevated M
activity in the Kae PT group was significantly decreased compared with the HSon MDA levels in the heart (P = 0.34), lung (P = 0.43),
and liver (P = 0.11) and on SOD activities in the heart
(P = 0.16), lung (P = 0.37), and liver (P = 0.25) compared
with the HS group. However, the injection of kaempferol
12 h prior to the induction of HS resulted in decreased
MDA levels (P = 0.012, 0.001, and 0.002, respectively)
and increased SOD activities (P = 0.032, 0.024, and 0.004,
respectively) compared with the HS group in the heart,
lung, and liver.
Expression of HO-1 in the heart, lung, and liver
This study found evidence of HO-1 expression in the
main organs including the heart, lung, and liver. As seen
in Figure 5, HO-1 expression was insignificantly in-
creased in the heart, lung, and liver in the HS group
compared with the Sham group (P = 0.37, 0.22, and
0.19, respectively). The injection of kaempferol follow-
ing HS showed no effects on HO-1 expression in organs
including the heart (P = 0.063), lung (P = 0.21), and liver
(P = 0.37) after HS, while the injection of kaempferol
12 h prior to the induction of HS resulted in sig-
nificantly increased expression of HO-1 in the heart
(P < 0.001), lung (P = 0.001), and liver (P < 0.001) com-
pared with the HS group.PO activities were observed in the heart, lung, and liver after HS. MPO
and Kae T groups. Compared with the other groups, #P< 0.05, ##P < 0.01.
Figure 4 Organ oxidative response after HS in all groups. MDA
levels (A) in the heart, lung, and liver were significantly increased,
while SOD activities (B) were significantly decreased in all experimental
groups after HS. Injection with kaempferol 12 h prior to the initiation of
HS resulted in a significant decrease of MDA levels and increase of
SOD activities. Compared with the other groups, #P < 0.05, ##P < 0.01.
Compared with the HS group or Kae T group, *P < 0.05, **P < 0.01.
Figure 5 HO-1 expression in heart, lung, and liver after HS. A, Western
with kaempferol 12 h prior to the initiation of HS resulted in a significant
with the other groups, **P < 0.01.
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In this study, we investigated the protective effects of
kaempferol in HS in mice. The injection of kaempferol
prior to the initiation of HS significantly decreased
serum proinflammatory cytokines and organ inflamma-
tion. Moreover, kaempferol showed its antioxidant ability
through inhibiting MDA expression and promoting SOD
activities in the heart, lung, and liver.
HS and subsequent ischemia/reperfusion injury are
associated with oxidative stress in organs [18,19], and it
has been proposed that this generated oxidative stress is
a fundamental mechanism of organ damage in HS [20].
Oxygen-free radicals are involved in HS and subsequent
resuscitation [21]. Wu et al. [22] confirmed that HS and
resuscitation induced significant oxidation in rat lungs,
while Panteli et al. [23] reported that the oxidative state
of the kidneys remained unaffected after HS. Treatment
with antioxidant agents after HS reduced organ oxidative
stress and led to a better outcome. Antioxidant therapy
with Tempol, a membrane-permeable radical scavenger,
improved outcome after HS in rats [24]. In our study,
HS and resuscitation induced significant oxidative stress
in the heart, lung, and liver, but pretreatment with
kaempferol decreased oxidative stress in these organs.
Oxidative stress in HS induces the activation of nu-
clear factor-κB (NF-κB), which triggers an inflammatory
cascade during acute hemorrhage, and leads to an over-
production of proinflammatory cytokines [25-27]. More-
over, oxidative stress during HS can induce accumulation
and activation of neutrophils and subsequent increases
in concentrations of inflammatory mediators, including
TNF-α and IL-6, in organs [28,29]. The TNF-α and IL-6
plasma levels were significantly increased after HS in our
study. In addition, the i.p. injection of kaempferol at a
single dose 12 h prior to the initiation of HS was associ-
ated with significantly decreased organ inflammation.
This finding was possibly a consequence of the reducedblot assay for HO-1 expression; B, relative density (HO-1/β-actin). Injection
increase of HO-1 expression in the heart, lung, and liver. Compared
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ment. One previous study found that the activation of
NF-κB could be attenuated by treatment with kaemp-
ferol [30]. Therefore, its anti-inflammatory and antioxi-
dant abilities in this study were possibly associated with
the inhibition of NF-κB expressions after HS.
Modulation of HO-1, also known as heat shock pro-
tein 32, is a promising approach to the attenuation of
organ damage [31]. HO-1 is a stress-inducible protein, and
its overexpression protects against ischemia-reperfusion
injury [32]. Up-regulation of HO-1 could lead to re-
markable cytoprotective effects and attenuate organ
damage after HS [33]. In addition, kaempferol protected
cells against apoptosis via inductions of HO-1 expres-
sion [34]. In this study, kaempferol pretreatment re-
sulted in significantly higher levels of HO-1 in major
organs including the heart, lung, and liver. Future studies
are needed to investigate whether kaempferol also exerts
its protective effects via the up-regulation of HO-1 in
tissues after HS.
Conclusions
Pretreatment with kaempferol of HS mice significantly
decreased plasma levels of TNF-α and IL-6; reverted
MPO, SOD, and MDA in the heart, lung, and liver; and
increased expression of HO-1 in the same organs.
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